Member Info for comeonvog

gazshot, hi. my stock was through Barclays and i now have the paper cert . I have called up H.L. computer shares A.J Bell but nobody wants to help me with this stock . They all told me to go back to Barclays but nothing doing . What to do now ???

With final results out within days i think we might get some positive movement in SP

"The first revenue on this contract was invoiced in January 2018 and we expect regular billing, on work completed and certified on a monthly basis, from now until the end of the contract period; the first payment from MTRC was received in mid-March 2018. In the year ended 31 March 2018, the Group invoiced HK$5.1 million to MTRC, leaving a further HK$402.2 million over the remaining five and a half years of the contract."

· Shandong Ruyi Group will be a majority shareholder in the Company and one or more Director(s) will be nominated by Shandong Ruyi Group to join the Board of Bagir, subject to the completion of the necessary regulatory due diligence.

Shandong Ruyi Group and Bagir will evaluate ways in which Shandong Ruyi Group can provide additional future operational support to Bagir.

With Shandong Ruyi Group as a key shareholder and partner we believe that Bagir will be best placed to exploit the opportunity presented by our Ethiopian manufacturing base far quicker and with more certainty than we could independently."

seer that was then this in now . totally different circumstances . Market correction late 2019/2020 but no crash. IMHO

yep , happy with that and roll on to the interims in September .

"With peer leading break-evens and plans to increase production we can grow profitability in the short-term whilst working up a further step-change from future developments."

Do people remember this from the Preliminary Results for the year ended 31 December 2017

Our objective is for our pain relief products to be best-in-class. The rationale for this is that the National Institute for Health and Care Excellence (NICE) gives clear guidance to physicians to prescribe topical NSAIDs in the first instance for joint pain associated with osteoarthritis, in preference to oral NSAIDs, owing to concerns over the long term use of oral NSAIDs. This means that the best-in-class topical treatment should be the first choice for doctors in the initial treatment of pain and therefore represents a substantial opportunity in a market with global sales estimated at US$2.9 billion3.

Some news on TPR100.

Got to be a big worked sell soon , somebody wants out.

yep , but if they were happy to reduce before the news then .....

RNS yesterday , could be the reason for the fall.

stuartw6040 , truth is only the select few know who is buying and selling. Yesterdays RNS was final confirmation of the deal struck last November , now we are in the consolidation period until next news. In/out your choice, i just added a few more at 2.65p.

DrAmbition , he is a troll end of.

Only a lucky few got in at 1.7p today , so how is that 100%.

Could still be selling and reason for the SP to stall .

Terrier54 look at the dates.

Now that was a bit of bad luck.

https://www.youtube.com/watch?v=tyHm8oqkOB0

think he was up late after watching Teletubbies all night.

Dbopp , really , thank's for that investment advice now move along plonker time bitty .

The Directors of Bagir believe that through forming this strategic partnership with Shandong Ruyi together with the significant increase in capital, the transaction has the potential to transform the Company and its ability to compete and win major apparel manufacturing contracts from the world's largest retailers.